This is the authors' abstract. We don't add key points for this paper.
The emergence of drug-resistant strains of Vibrio cholerae , coupled with the current limitations of oral vaccines, underscores the urgent need for the development of new vaccines. The O-antigen of V. cholerae serotype O100 has emerged as a promising candidate for vaccine development. To investigate the absolute configuration of 3,5-dihydroxyhexanoyl (dHh) and to evaluate the structure-activity relationship of the O-antigen trisaccharide repeating unit, we completed total synthesis of four potential trisaccharide isomers, along with 11 additional oligosaccharide fragments of the O-antigen. Stereoselective reduction was used for the synthesis of dHh, and the efficient assembly of dHh and ( R )-3-hydroxybutanoyl ( R Hb) was achieved through a post-glycosylation modification strategy. Through NMR analysis, the absolute configuration of dHh was assigned 3 S ,5 S . Glycan microarray screening indicated that R Hb is essential for the antigenicity of O-antigen. The nonreducing end disaccharide 59 may serve as the minimal antigenic epitope. These findings are an important step toward the design of semi-synthetic carbohydrate vaccines against V. cholerae .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: